Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 β-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community

Nancy D. Hanson, Ellen Smith Moland, S. G. Hong, Katie Propst, Deborah J. Novak, Stephen J. Cavalieri

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

β-Lactamases produced by urine isolates from patients in long-term care facilities (LTCFs), outpatient, clinics, and one hospital in a U.S. community were characterized. A total of 1.3% of all Escherichia coli and Klebsiella pneumoniae isolates collected from patients in 30 LTCFs and various outpatient clinics produced extended-spectrum β-lactamases (ESBLs) and/or imported AmpC β-lactamases.

Original languageEnglish
Pages (from-to)3814-3816
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume52
Issue number10
DOIs
StatePublished - Oct 2008

Fingerprint

Klebsiella pneumoniae
Long-Term Care
Urine
Hospital Outpatient Clinics
Escherichia coli
Ambulatory Care Facilities
Asp(5)-oxytocin

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)
  • Pharmacology
  • Infectious Diseases

Cite this

Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 β-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community. / Hanson, Nancy D.; Moland, Ellen Smith; Hong, S. G.; Propst, Katie; Novak, Deborah J.; Cavalieri, Stephen J.

In: Antimicrobial Agents and Chemotherapy, Vol. 52, No. 10, 10.2008, p. 3814-3816.

Research output: Contribution to journalArticle

@article{edbe91da15cd4d1eb22100fb2f0dd1a4,
title = "Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 β-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community",
abstract = "β-Lactamases produced by urine isolates from patients in long-term care facilities (LTCFs), outpatient, clinics, and one hospital in a U.S. community were characterized. A total of 1.3{\%} of all Escherichia coli and Klebsiella pneumoniae isolates collected from patients in 30 LTCFs and various outpatient clinics produced extended-spectrum β-lactamases (ESBLs) and/or imported AmpC β-lactamases.",
author = "Hanson, {Nancy D.} and Moland, {Ellen Smith} and Hong, {S. G.} and Katie Propst and Novak, {Deborah J.} and Cavalieri, {Stephen J.}",
year = "2008",
month = "10",
doi = "10.1128/AAC.00877-08",
language = "English",
volume = "52",
pages = "3814--3816",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "10",

}

TY - JOUR

T1 - Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 β-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community

AU - Hanson, Nancy D.

AU - Moland, Ellen Smith

AU - Hong, S. G.

AU - Propst, Katie

AU - Novak, Deborah J.

AU - Cavalieri, Stephen J.

PY - 2008/10

Y1 - 2008/10

N2 - β-Lactamases produced by urine isolates from patients in long-term care facilities (LTCFs), outpatient, clinics, and one hospital in a U.S. community were characterized. A total of 1.3% of all Escherichia coli and Klebsiella pneumoniae isolates collected from patients in 30 LTCFs and various outpatient clinics produced extended-spectrum β-lactamases (ESBLs) and/or imported AmpC β-lactamases.

AB - β-Lactamases produced by urine isolates from patients in long-term care facilities (LTCFs), outpatient, clinics, and one hospital in a U.S. community were characterized. A total of 1.3% of all Escherichia coli and Klebsiella pneumoniae isolates collected from patients in 30 LTCFs and various outpatient clinics produced extended-spectrum β-lactamases (ESBLs) and/or imported AmpC β-lactamases.

UR - http://www.scopus.com/inward/record.url?scp=54049102057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54049102057&partnerID=8YFLogxK

U2 - 10.1128/AAC.00877-08

DO - 10.1128/AAC.00877-08

M3 - Article

C2 - 18663030

AN - SCOPUS:54049102057

VL - 52

SP - 3814

EP - 3816

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 10

ER -